Skip to the main content
The Crier

NHS Framework Agreement for the supply of Ranibizumab for the NHS in England

NHS EnglandYorkshire and The HumbergoodsFramework
Your saved contracts

What the buyer wrote

The Procurement relates to the supply of ranibizumab an Anti Veg-F medicine used in medical retinal vascular services for the NHS in England.<br/>Anti Veg-F medicines are currently used in the treatment of: <br/>a. neovascular (wet) age-related macular degeneration (AMD);<br/>b. visual impairment due to diabetic macular oedema (DME/DMO);<br/>c. visual impairment due to myopic choroidal neovascularisation (myopic CNV); and<br/>d. visual impairment due to macular oedema secondary to retinal vein occlusion (branch RVO or central RVO).

Details

What the buyer calls it
NHS Framework Agreement for the supply of Ranibizumab for the NHS in England
How they are buying
Advertised, open to anyoneAny supplier could bid without being invited first.
Type
goods
Framework
Yes: joining it lets you bid for call-offs without a new tender each time
Where
in Yorkshire and The Humber

Who the buyer named

NHSE Commercial was the named contact on this notice.

england.commercialqueries@nhs.net